Company intelligence / Profile preview

NysnoBio

Mill Valley, California, United Statesnysnobio.com ↗
Ownership
Private
Employees
~38
Development stage
Preclinical
01

Overview

NysnoBio’s lead program NB001, an AAV-based Parkin gene replacement therapy for genetically defined early-onset Parkinson’s disease, has completed preclinical proof-of-concept and safety studies. The company received funding from the Michael J. Fox Foundation to support manufacturing and IND-enabling studies. No human clinical results reported yet; first-in-human trials are anticipated following successful completion of these studies.

Therapeutic areas
Neurology
Modalities
Gene therapyAAV-based gene therapy (Adeno-associated virus vector)
Industry
Biotech
02

Drug pipeline

3 assets

NB004 (NysnoBio)

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

Michael J. Fox Foundation for Parkinson’s Research ("MJFF") [funding partner/supporter of research and development efforts on NB001 and biomarkers].

Beyond the preview

Go deeper on NysnoBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NysnoBio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call